Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$94.79
-0.56-0.59%
At close: Dec 15, 4:00 PM EST
$94.79
N/A
After Hours: 4:07 PM EST
Comments
Loading...
Protagonist Therapeutics (PTGX) Stock Price, Quote, News & History
PTGXNASDAQ
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Protagonist Therapeutics (PTGX) stock?
You can purchase shares of Protagonist Therapeutics (NASDAQ:PTGX) through any online brokerage.
Who are Protagonist Therapeutics (PTGX) competitors?
Other companies in Protagonist Therapeutics’s space includes: Immunovant Inc (NASDAQ:IMVT), Cogent Biosciences Inc (NASDAQ:COGT), Celcuity Inc (NASDAQ:CELC), Alkermes PLC (NASDAQ:ALKS) and PTC Therapeutics Inc (NASDAQ:PTCT).
What is the forecast, or price target, for Protagonist Therapeutics (PTGX) stock?
Protagonist Therapeutics has a consensus price target of $75.67.
What is the current price for Protagonist Therapeutics (PTGX)?
The stock price for Protagonist Therapeutics (NASDAQ: PTGX) is $94.79 last updated December 15, 2025 at 4:07 PM EST.
Does Protagonist Therapeutics (PTGX) pay a dividend?
There are no upcoming dividends for Protagonist Therapeutics.
When is Protagonist Therapeutics (NASDAQ:PTGX) reporting earnings?
Protagonist Therapeutics does not have any upcoming earnings scheduled.
Is Protagonist Therapeutics (PTGX) going to split?
There is no upcoming split for Protagonist Therapeutics.
What sector and industry does Protagonist Therapeutics (PTGX) operate in?
Protagonist Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
